1 January 2022 in Journal of Inflammation Research
Objective: Oral squamous cell carcinoma (OSCC) is the most frequent oral malignancy with a poor prognosis, in which tumor-infiltrating immune cells may play a critical role. Therefore, our study aims to screen potential immune cells and immune-related genes for predicting OSCC prognosis. Methods: A total of 310 OSCC patients with full transcriptional data and clinical characteristics were extracted from the TCGA database. Then, we obtained their abundance of tumor-infiltrating immune cells on TIMER 2.0 and analyzed them using xCell method. Univariate and multivariate Cox regressions were applied successively to identify the immune cells associated with overall survival of OSCC patients. Furthermore, we screened the prognostic genes that related to the identified immune cells and validated their expressions by immunohistochemistry. Results: CD4+ central memory T (TCM) cell was recognized as the sole independent immune cell correlated with OSCC prognosis (p = 0.0085). A novel nomogram based on CD4+ TCM cell abundance was established for predicting the prognosis of OSCC patients, with calibration plots showing good performance for 1-, 3-, 5-year overall survival. Thirty-four related prognostic genes were screened according to the differential abundance of CD4+ TCM cell infiltration. In immunohistochemistry analysis, DEFB1 showed a significant positive relationship with the density of CD4+ TCM cells (p = 0.0075). Conclusion: CD4+ central memory T cell was proposed as an independent prognostic biomarker for OSCC patients. DEFB1 might positively regulate the abundance of tumor-infiltrating CD4+ TCM cells, thus improving OSCC prognosis. Our findings may provide a new insight into better prognosis prediction and precise medicine for OSCC.
1 July 2025 in Journal of Oral Pathology & Medicine
30 July 2025 in Journal of Oral Pathology & Medicine
1 March 2026 in International Journal of General Medicine
The prognostic impact of betel nut on oral squamous cell carcinoma (OSCC) remains controversial. This study aimed to determine whether betel nut chewing is an independent prognostic factor in patients treated with standardized surgery. This retrospective population-based cohort study enrolled 1113 patients with primary OSCC, including 922 betel nut chewers and 191 non-chewers. All patients underwent standardized surgical treatment. The prognostic impact of betel nut chewing was evaluated by returning to all patients and comparing the disease-free survival times between the two groups. The Chi-square test was used to explore the clinical characteristics associated with betel nut chewing. Kaplan-Meier survival analysis, univariable Cox regression, and multivariable Cox regression analyses were used to investigate the prognostic impact of betel nut. No significant difference was observed in the disease-free survival time between chewers and non-chewers in either the overall group or subgroup analyses. Univariable Cox regression analysis indicated that betel nut use was not a prognostic factor. After adjusting for potential confounders, multivariable Cox regression confirmed that cervical lymph node metastasis, clinical stage, and pathological grade were independent risk factors for prognosis, whereas betel nut use had no significant impact on prognosis. These findings suggest that the prognosis of OSCC is dictated by the biological stage of the tumor rather than betel nut use. This allows clinicians to develop more objective, precise treatment plans for OSCC patients.